N. Jones

发表

MUTYH-associated polyposis.

J. Sampson, N. Jones, N. Jones, 2009, Best practice & research. Clinical gastroenterology.

Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH.

D. Evans, P. Wark, J. Sampson, 2009, Gastroenterology.

Molecular genetic and phenotypic characteristics of patients with adenomatous colorectal polyposis

N. Jones, N. Jones, 2008 .

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.

C. Engel, P. Propping, J. Sampson, 2009, Gastroenterology.

Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations

Gaëtan MacGrogan, Aurélien de Reyniès, E. Letouzé, 2012, PloS one.

53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy

O. Sansom, A. Clarke, Y. Adachi, 2007, Oncogene.

Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.

Kristilyn Eliason, Brant C Hendrickson, Thomas Scholl, 2008, Cancer research.

Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

F. Révillion, R. Lidereau, N. Sevenet, 2021, American journal of human genetics.

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis.

C. Engel, P. Propping, J. Sampson, 2009, Gastroenterology.

Analysis of MUTYH genotypes and colorectal phenotypes in patients With MUTYH-associated polyposis.

J. Sampson, H. Vasen, S. Aretz, 2009, Gastroenterology.

Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3

V. Moskvina, R. Houlston, D. Evans, 2008, Gut.

Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: A proof of principle study

E. Letouzé, G. MacGrogan, N. Sevenet, 2017, Genes, chromosomes & cancer.

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

V. Brouste, I. de Mascarel, G. MacGrogan, 2012, BMC Medical Genomics.